|
Nov 9
|
Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences
|
|
Nov 8
|
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights
|
|
Nov 7
|
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023
|
|
Nov 3
|
Here's Why We're Watching Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation
|